DE3778225D1 - Antibiotikum ll-e19020 alpha und beta. - Google Patents

Antibiotikum ll-e19020 alpha und beta.

Info

Publication number
DE3778225D1
DE3778225D1 DE8787109199T DE3778225T DE3778225D1 DE 3778225 D1 DE3778225 D1 DE 3778225D1 DE 8787109199 T DE8787109199 T DE 8787109199T DE 3778225 T DE3778225 T DE 3778225T DE 3778225 D1 DE3778225 D1 DE 3778225D1
Authority
DE
Germany
Prior art keywords
antibiotic
beta
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787109199T
Other languages
English (en)
Inventor
Guy Thomas Carter
Michael Greenstein
Joseph Jacob Goodman J Goodman
Donald Bruce Borders
William Michael Maiese
Raymond Thomas Testa
Irwin Boyden Wood
Mary Eulers Doscher
Sidney Kantor
Kennett, Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/880,230 external-priority patent/US4705688A/en
Priority claimed from US06/880,608 external-priority patent/US4704276A/en
Priority claimed from US06/880,229 external-priority patent/US4753798A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DE3778225D1 publication Critical patent/DE3778225D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00—Antibiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Animal Husbandry (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8787109199T 1986-06-30 1987-06-26 Antibiotikum ll-e19020 alpha und beta. Expired - Fee Related DE3778225D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88023986A 1986-06-30 1986-06-30
US06/880,230 US4705688A (en) 1986-06-30 1986-06-30 Antibiotic LL-E19020 α and β
US06/880,608 US4704276A (en) 1986-06-30 1986-06-30 Compositions and methods for increasing the growth rate of meat producing animals, improving the efficiency of feed utilization thereby and enhancing lactation in lactating ruminants
US06/880,229 US4753798A (en) 1986-06-30 1986-06-30 Methods and compositions for controlling protozoal infections in warm-blooded animals

Publications (1)

Publication Number Publication Date
DE3778225D1 true DE3778225D1 (de) 1992-05-21

Family

ID=27505969

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787109199T Expired - Fee Related DE3778225D1 (de) 1986-06-30 1987-06-26 Antibiotikum ll-e19020 alpha und beta.

Country Status (11)

Country Link
EP (1) EP0252380B1 (de)
JP (2) JP2535544B2 (de)
KR (1) KR950000983B1 (de)
CA (1) CA1338168C (de)
DE (1) DE3778225D1 (de)
DK (1) DK170282B1 (de)
ES (1) ES2051712T3 (de)
GR (1) GR3004369T3 (de)
IE (1) IE60758B1 (de)
IL (1) IL83025A (de)
NZ (1) NZ220900A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE105192T1 (de) * 1987-10-29 1994-05-15 American Cyanamid Co Methode fuer die kontrolle von chronischer atmungskrankheit und nekrotischer enteritis bei voegeln.
US5204361A (en) * 1988-03-30 1993-04-20 Rowe James B Method for treating laminitis in equine livestock
US5077277A (en) * 1989-09-05 1991-12-31 American Cyanamid Company Chemical derivatives of antibiotics ll-e19020 alpha and beta
FR2657873B1 (fr) * 1990-02-08 1992-04-17 Rhone Poulenc Sante Nouvelle elfamycine, son procede de preparation et son utilisation.
US5814615A (en) * 1991-09-09 1998-09-29 Roche Vitamins Inc. Antibiotic LL-E19020 Alpha1
WO1993013217A1 (en) * 1991-12-27 1993-07-08 Gruppo Lepetit S.P.A. Antibiotic ge 21640a
KR100404067B1 (ko) * 2001-01-04 2003-11-01 주식회사 이지바이오시스템 유기태 셀레늄 함유 홍보리쌀 및 그의 제조방법
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens

Also Published As

Publication number Publication date
AU596672B2 (en) 1990-05-10
IE871731L (en) 1987-12-30
ES2051712T3 (es) 1994-07-01
EP0252380A3 (en) 1988-09-14
JPH08205856A (ja) 1996-08-13
CA1338168C (en) 1996-03-19
KR880000457A (ko) 1988-03-26
AU7490187A (en) 1988-01-07
JP2535544B2 (ja) 1996-09-18
NZ220900A (en) 1990-09-26
DK332287D0 (da) 1987-06-29
EP0252380A2 (de) 1988-01-13
EP0252380B1 (de) 1992-04-15
DK170282B1 (da) 1995-07-24
GR3004369T3 (de) 1993-03-31
KR950000983B1 (en) 1995-02-06
JPS6366191A (ja) 1988-03-24
JP2572562B2 (ja) 1997-01-16
IE60758B1 (en) 1994-08-10
DK332287A (da) 1987-12-31
IL83025A (en) 1992-01-15
IL83025A0 (en) 1987-12-20

Similar Documents

Publication Publication Date Title
IT8720584A0 (it) Tetraidronaftalin- derivati e indan-derivati
DE3687279T2 (de) Beta-lactam-antibiotika.
DK100886D0 (da) Antibiotiske clathrater
NO894790D0 (no) Beta-aminoboronsyrederivater.
DK673087D0 (da) Benzoxazinyl- og benzothiazinylpyridazinonforbindelser
DK39587D0 (da) Antibiotiske glycopeptider
KR880701451A (ko) 개 폐 기
FI874939A (fi) Antibiotiska foereningar.
DE3778225D1 (de) Antibiotikum ll-e19020 alpha und beta.
DE3766441D1 (de) Anilinotriazine und deren verwendung.
DE3789264D1 (de) Beta-lactam-antibiotika.
DK664287A (da) Antibiotisk fodertilsaetning
DK125287D0 (da) Macrolidforbindelser
DK387287D0 (da) Glycopeptidantibiotika
TR23713A (tr) Suebstituye edilmis tiouereler,izotiouereler ve korbadiimetiller
ATE74925T1 (de) Antibiotikum ll-e19020 alpha und beta.
ZA874729B (en) Antibiotic ll-e19020 alpha and beta
DE3786795T2 (de) Antibiotikum yi-hu3 und herstellungsverfahren.
DE3769167D1 (de) Aerocavin- und aerocyanidin-antibiotika.
DE3777385D1 (de) Alpha-acyloxyketon-derivate.
AU596672C (en) Antibiotic LL-E19020 alpha and beta
IT8521389A0 (it) Nuovo antibiotico macrolidico e suo procedimento di preparazione.
IT8421853A0 (it) Nuovo antibiotico macrolidico e suo procedimento di preparazione.
ATE45364T1 (de) Antibiotika m43a, m43b, m43c und m43d.
KR880005977U (ko) 쑥뜸구

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: F. HOFFMANN-LA ROCHE AG, BASEL, CH

8339 Ceased/non-payment of the annual fee